Paula Marie Ragan,Robert D. Arbeit,Kieran James Crowley
申请号：
US16061974
公开号：
US20180369229A1
申请日:
2016.12.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to methods of treating patients with advanced forms of cancer, such as clear cell renal cell carcinoma, in which X4P-001 is administered in order to reduce angiogenic escape that typically occurs with TKI therapy. The methods demonstrate surprising results, including regression of tumor size and cell number, with comparatively little toxicity.
